Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene, ENSG00000289582, also referred to as a "novel transcript, sense intronic to GBP2," encodes a long non-coding RNA (lncRNA).[5] It is not a protein-coding gene and does not represent a classic molecular target such as a receptor, enzyme, transporter, or transcription factor. There are currently no established molecular functions, disease associations, or known interactions with drugs for this transcript. No recognized use as a biomarker or information about safety concerns has been documented. Given its lncRNA status and lack of experimental characterization, this entry should not be considered a validated molecular target for therapeutic development or clinical research at this time.[5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to GBP2 (ENSG00000289582).